Comprehensive analysis of L-PRF exudate components and their impact on whole blood platelets.


Journal

Clinical oral investigations
ISSN: 1436-3771
Titre abrégé: Clin Oral Investig
Pays: Germany
ID NLM: 9707115

Informations de publication

Date de publication:
07 Aug 2024
Historique:
received: 28 11 2023
accepted: 31 07 2024
medline: 7 8 2024
pubmed: 7 8 2024
entrez: 7 8 2024
Statut: epublish

Résumé

This study assessed the cellular composition and effects of leukocyte-platelet-rich fibrin (L-PRF) exudate on whole blood platelets from healthy volunteers. Key objectives included evaluating leukocyte subpopulations, platelet activation markers, platelet-leukocyte interactions and quantifying inflammatory cytokines within the L-PRF exudate. L-PRF was obtained from 20 healthy donors. Flow cytometry methodologies were used to assess intracellular calcium kinetics and activated GPIIbIIIa, and P-selectin expression. Leukocyte subpopulations and platelet-leukocyte interactions were characterized using monoclonal antibodies. Inflammatory cytokines (IL-8, IL-1β, IL-6, IL-10, TNF, IL-12p70) within L-PRF exudate were quantified using a cytometric bead array. The expression of activated GPIIbIIIa, and P-selectin exhibited a significant increase (p < 0.001) when L-PRF exudate was added to platelets of whole blood. Regarding intracellular Ca Despite the study limitations, the research yielded important insights: 1- L-PRF exudate can stimulate platelet activation, essential in healing, tissue inflammation and remodeling. 2-The presence of leukocyte subpopulations within L-PRF exudate reflexes its complexity and potential to enhance immune responses. 3-The analysis of inflammatory cytokines within L-PRF exudate revealed its immunomodulatory potential. These findings are valuable evidences for understanding the potential role of L-PRF exudate in regenerative dentistry and medicine, offering innovative therapeutic strategies. This research highlights crucial aspects that could significantly influence the clinical use of L-PRF exudate in the oral cavity. The findings support the application of L-PRF exudate in both surgical and regenerative dentistry, facilitating the development of innovative therapeutic strategies to enhance patient outcomes.

Identifiants

pubmed: 39110266
doi: 10.1007/s00784-024-05868-z
pii: 10.1007/s00784-024-05868-z
doi:

Substances chimiques

Cytokines 0
Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

470

Subventions

Organisme : UNIPRO - Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), CESPU and 1H-TOXRUN - One Health Toxicology Research Unit, University Institute of Health Sciences (IUCS), CESPU
ID : PAAALPRF_PI2RL_IINFACTS_2021
Organisme : UNIPRO - Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), CESPU and 1H-TOXRUN - One Health Toxicology Research Unit, University Institute of Health Sciences (IUCS), CESPU
ID : PAAALPRF_PI2RL_IINFACTS_2021
Organisme : UNIPRO - Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), CESPU and 1H-TOXRUN - One Health Toxicology Research Unit, University Institute of Health Sciences (IUCS), CESPU
ID : PAAALPRF_PI2RL_IINFACTS_2021
Organisme : UNIPRO - Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), CESPU and 1H-TOXRUN - One Health Toxicology Research Unit, University Institute of Health Sciences (IUCS), CESPU
ID : PAAALPRF_PI2RL_IINFACTS_2021
Organisme : UNIPRO - Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), CESPU and 1H-TOXRUN - One Health Toxicology Research Unit, University Institute of Health Sciences (IUCS), CESPU
ID : PAAALPRF_PI2RL_IINFACTS_2021

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Puricelli C, Boggio E, Gigliotti CL et al (2023) Platelets, protean cells with all-around functions and multifaceted pharmacological applications. Int J Mol Sci 24:4565. https://doi.org/10.3390/ijms24054565
doi: 10.3390/ijms24054565 pubmed: 36901997 pmcid: 10002540
Theofilis P, Sagris M, Oikonomou E et al (2022) Factors associated with platelet activation-recent pharmaceutical approaches. Int J Mol Sci 23:3301. https://doi.org/10.3390/ijms23063301
doi: 10.3390/ijms23063301 pubmed: 35328719 pmcid: 8955963
Jain A, Graveline A, Waterhouse A et al (2016) A shear gradient-activated microfluidic device for automated monitoring of whole blood haemostasis and platelet function. Nat Commun 7:10176. https://doi.org/10.1038/ncomms10176
doi: 10.1038/ncomms10176 pubmed: 26733371 pmcid: 4729824
Blair P, Flaumenhaft R (2009) Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 23:177–189. https://doi.org/10.1016/j.blre.2009.04.001
doi: 10.1016/j.blre.2009.04.001 pubmed: 19450911 pmcid: 2720568
Gassling VLW, Açil Y, Springer IN et al (2009) Platelet-rich plasma and platelet-rich fibrin in human cell culture. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108:48–55. https://doi.org/10.1016/j.tripleo.2009.02.007
doi: 10.1016/j.tripleo.2009.02.007 pubmed: 19451011
van Dooren FH, Duijvis NW, te Velde AA (2013) Analysis of cytokines and chemokines produced by whole blood, peripheral mononuclear and polymorphonuclear cells. J Immunol Methods 396:128–133. https://doi.org/10.1016/j.jim.2013.08.006
doi: 10.1016/j.jim.2013.08.006 pubmed: 23994257
Davis VL, Abukabda AB, Radio NM et al (2014) Platelet-rich preparations to improve healing. Part II: platelet activation and enrichment, leukocyte inclusion, and other selection criteria. J Oral Implantol 40:511–521. https://doi.org/10.1563/AAID-JOI-D-12-00106
doi: 10.1563/AAID-JOI-D-12-00106 pubmed: 25106017
Jiménez-Aristizabal RF, López C, Álvarez ME et al (2017) Long-term cytokine and growth factor release from equine platelet-rich fibrin clots obtained with two different centrifugation protocols. Cytokine 97:149–155. https://doi.org/10.1016/j.cyto.2017.06.011
doi: 10.1016/j.cyto.2017.06.011 pubmed: 28648869
Toffler M (2014) Guided bone regeneration (GBR) using cortical bone pins in combination with leukocyte- and platelet-rich fibrin (L-PRF). Compend Contin Educ Dent 35:192–198
pubmed: 24773199
Panda S, Karanxha L, Goker F et al (2019) Autologous platelet concentrates in treatment of furcation defects-a systematic review and meta-analysis. Int J Mol Sci 20:1347. https://doi.org/10.3390/ijms20061347
doi: 10.3390/ijms20061347 pubmed: 30884920 pmcid: 6470588
Ding Z-Y, Tan Y, Peng Q et al (2021) Novel applications of platelet concentrates in tissue regeneration (review). Exp Ther Med 21:226. https://doi.org/10.3892/etm.2021.9657
doi: 10.3892/etm.2021.9657 pubmed: 33603835 pmcid: 7851614
Miron RJ, Zucchelli G, Pikos MA et al (2017) Use of platelet-rich fibrin in regenerative dentistry: a systematic review. Clin Oral Investig 21:1913–1927. https://doi.org/10.1007/s00784-017-2133-z
doi: 10.1007/s00784-017-2133-z pubmed: 28551729
Dohan DM, Choukroun J, Diss A et al (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:e37–44. https://doi.org/10.1016/j.tripleo.2005.07.008
doi: 10.1016/j.tripleo.2005.07.008 pubmed: 16504849
Saluja H, Dehane V, Mahindra U (2011) Platelet-rich fibrin: a second generation platelet concentrate and a new friend of oral and maxillofacial surgeons. Ann Maxillofac Surg 1:53–57. https://doi.org/10.4103/2231-0746.83158
doi: 10.4103/2231-0746.83158 pubmed: 23482459 pmcid: 3591032
Karimi K, Rockwell H (2019) The benefits of platelet-rich fibrin. Facial Plast Surg Clin North Am 27:331–340. https://doi.org/10.1016/j.fsc.2019.03.005
doi: 10.1016/j.fsc.2019.03.005 pubmed: 31280847
Pinto NR, Ubilla M, Zamora Y et al (2018) Leucocyte- and platelet-rich fibrin (L-PRF) as a regenerative medicine strategy for the treatment of refractory leg ulcers: a prospective cohort study. Platelets 29:468–475. https://doi.org/10.1080/09537104.2017.1327654
doi: 10.1080/09537104.2017.1327654 pubmed: 28727481
Dohan Ehrenfest DM, Del Corso M, Diss A et al (2010) Three-dimensional architecture and cell composition of a Choukroun’s platelet-rich fibrin clot and membrane. J Periodontol 81:546–555. https://doi.org/10.1902/jop.2009.090531
doi: 10.1902/jop.2009.090531 pubmed: 20373539
Yaprak E, Kasap M, Akpinar G et al (2018) Abundant proteins in platelet-rich fibrin and their potential contribution to wound healing: an explorative proteomics study and review of the literature. J Dent Sci 13:386–395. https://doi.org/10.1016/j.jds.2018.08.004
doi: 10.1016/j.jds.2018.08.004 pubmed: 30895150 pmcid: 6388803
Giannotti L, Di Chiara Stanca B, Spedicato F et al (2023) Progress in regenerative medicine: exploring autologous platelet concentrates and their clinical applications. Genes 14:1669. https://doi.org/10.3390/genes14091669
doi: 10.3390/genes14091669 pubmed: 37761809 pmcid: 10530962
Borie E, Oliví DG, Orsi IA et al (2015) Platelet-rich fibrin application in dentistry: a literature review. Int J Clin Exp Med 8:7922–7929
pubmed: 26221349 pmcid: 4509294
Wang X, Fok MR, Pelekos G et al (2022) Increased local concentrations of growth factors from leucocyte- and platelet-rich fibrin do not translate into improved alveolar ridge preservation: an intra-individual mechanistic randomized controlled trial. J Clin Periodontol 49:889–898. https://doi.org/10.1111/jcpe.13688
doi: 10.1111/jcpe.13688 pubmed: 35734895
Dohan DM, Choukroun J, Diss A et al (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:e45–50. https://doi.org/10.1016/j.tripleo.2005.07.009
doi: 10.1016/j.tripleo.2005.07.009 pubmed: 16504850
Micko L, Salma I, Skadins I et al (2023) Can our blood help ensure antimicrobial and anti-inflammatory properties in oral and maxillofacial surgery? Int J Mol Sci 24:1073. https://doi.org/10.3390/ijms24021073
doi: 10.3390/ijms24021073 pubmed: 36674589 pmcid: 9863626
Melo-Ferraz A, Coelho C, Miller P et al (2021) Platelet activation and antimicrobial activity of L-PRF: a preliminary study. Mol Biol Rep 48:4573–4580. https://doi.org/10.1007/s11033-021-06487-7
doi: 10.1007/s11033-021-06487-7 pubmed: 34146200
Castro AB, Herrero ER, Slomka V et al (2019) Antimicrobial capacity of leucocyte-and platelet rich fibrin against periodontal pathogens. Sci Rep 9:8188. https://doi.org/10.1038/s41598-019-44755-6
doi: 10.1038/s41598-019-44755-6 pubmed: 31160643 pmcid: 6547693
Badade PS, Mahale SA, Panjwani AA et al (2016) Antimicrobial effect of platelet-rich plasma and platelet-rich fibrin. Indian J Dent Res 27:300–304. https://doi.org/10.4103/0970-9290.186231
doi: 10.4103/0970-9290.186231 pubmed: 27411660
Madurantakam P, Yoganarasimha S, Hasan FK (2015) Characterization of leukocyte-platelet rich fibrin, a novel biomaterial. J Vis Exp 53221. https://doi.org/10.3791/53221
Kobayashi E, Flückiger L, Fujioka-Kobayashi M et al (2016) Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Investig 20:2353–2360. https://doi.org/10.1007/s00784-016-1719-1
doi: 10.1007/s00784-016-1719-1 pubmed: 26809431
Wang Z, Mudalal M, Sun Y et al (2020) The effects of leukocyte-platelet rich fibrin (L-PRF) on suppression of the expressions of the pro-inflammatory cytokines, and proliferation of Schwann cell, and neurotrophic factors. Sci Rep 10:2421. https://doi.org/10.1038/s41598-020-59319-2
doi: 10.1038/s41598-020-59319-2 pubmed: 32051476 pmcid: 7016122
Wang X, Fok MR, Pelekos G et al (2022) In vitro and ex vivo kinetic release profile of growth factors and cytokines from leucocyte- and platelet-rich fibrin (L-PRF) preparations. https://doi.org/10.3390/cells11132089 . Cells 11:2089
Miron RJ, Pinto NR, Quirynen M, Ghanaati S (2019) Standardization of relative centrifugal forces in studies related to platelet-rich fibrin. J Periodontol 90:817–820. https://doi.org/10.1002/JPER.18-0553
doi: 10.1002/JPER.18-0553 pubmed: 30730050
Miron R, Choukroun J, Ghanaati S (2018) Controversies related to scientific report describing g-forces from studies on platelet-rich fibrin: necessity for standardization of relative centrifugal force values. Int J Growth Factors Stem Cells Dentistry 1. https://doi.org/10.4103/GFSC.GFSC_23_18
Pinto N, Temmerman A, Castro A et al (2017) Guidelines for the use of L-PRF flow charts: step by step approach leucocytes and platelet rich fibrin in different intra-oral applications applying the IntraSpin
do Céu Monteiro M, Sansonetty F, Gonçalves MJ, O’Connor JE (1999) Flow cytometric kinetic assay of calcium mobilization in whole blood platelets using Fluo-3 and CD41. Cytometry 35:302–310
doi: 10.1002/(SICI)1097-0320(19990401)35:4<302::AID-CYTO2>3.0.CO;2-J pubmed: 10213195
Schmitz G, Rothe G, Ruf A et al (1998) European working group on clinical cell analysis: consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 79:885–896
doi: 10.1055/s-0037-1615088 pubmed: 9609215
Pavlovic V, Ciric M, Jovanovic V et al (2021) Platelet-rich fibrin: basics of biological actions and protocol modifications. Open Med (Wars) 16:446–454. https://doi.org/10.1515/med-2021-0259
doi: 10.1515/med-2021-0259 pubmed: 33778163
McEver RP (1994) Selectins. Curr Opin Immunol 6:75–84. https://doi.org/10.1016/0952-7915(94)90037-x
doi: 10.1016/0952-7915(94)90037-x pubmed: 7513527
Kappelmayer J, Nagy B, Miszti-Blasius K et al (2004) The emerging value of P-selectin as a disease marker. Clin Chem Lab Med 42:475–486. https://doi.org/10.1515/CCLM.2004.082
doi: 10.1515/CCLM.2004.082 pubmed: 15202782
Shattil SJ, Hoxie JA, Cunningham M, Brass LF (1985) Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem 260:11107–11114
doi: 10.1016/S0021-9258(17)39154-8 pubmed: 2411729
Bielecki T, Dohan Ehrenfest DM, Everts PA, Wiczkowski A (2012) The role of leukocytes from L-PRP/L-PRF in wound healing and immune defense: new perspectives. Curr Pharm Biotechnol 13:1153–1162. https://doi.org/10.2174/138920112800624373
doi: 10.2174/138920112800624373 pubmed: 21740376
Ratajczak J, Vangansewinkel T, Gervois P et al (2018) Angiogenic properties of ‘Leukocyte- and platelet-rich fibrin.’ Sci Rep 8:14632. https://doi.org/10.1038/s41598-018-32936-8
doi: 10.1038/s41598-018-32936-8 pubmed: 30279483
Castro AB, Cortellini S, Temmerman A et al (2019) Characterization of the leukocyte- and platelet-rich fibrin block: release of growth factors, cellular content, and structure. Int J Oral Maxillofac Implants 34:855–864. https://doi.org/10.11607/jomi.7275
doi: 10.11607/jomi.7275 pubmed: 30742137
Cerletti C, de Gaetano G, Lorenzet R (2010) Platelet - leukocyte interactions: multiple links between inflammation, blood coagulation and vascular risk. Mediterr J Hematol Infect Dis 2:e2010023. https://doi.org/10.4084/MJHID.2010.023
doi: 10.4084/MJHID.2010.023 pubmed: 21415976 pmcid: 3033146
Jasmine S, Thangavelu A, Krishnamoorthy R et al (2021) Cytokine expression pattern and protein-protein interaction network analysis of leucocyte rich platelet rich fibrin and injectable form of platelet rich fibrin. Oral Maxillofac Surg 25:223–229. https://doi.org/10.1007/s10006-020-00899-8
doi: 10.1007/s10006-020-00899-8 pubmed: 32915342
Zhang J-M, An J (2007) Cytokines, inflammation and pain. Int Anesthesiol Clin 45:27–37. https://doi.org/10.1097/AIA.0b013e318034194e
doi: 10.1097/AIA.0b013e318034194e pubmed: 17426506 pmcid: 2785020
Choukroun J, Ghanaati S (2018) Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients’ own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept. Eur J Trauma Emerg Surg 44:87–95. https://doi.org/10.1007/s00068-017-0767-9
doi: 10.1007/s00068-017-0767-9 pubmed: 28283682
Yu Z, Kastenmüller G, He Y et al (2011) Differences between human plasma and serum metabolite profiles. PLoS ONE 6:e21230. https://doi.org/10.1371/journal.pone.0021230
doi: 10.1371/journal.pone.0021230 pubmed: 21760889 pmcid: 3132215
Pochini A, de Antonioli C, Bucci E DZ, et al (2016) Analysis of cytokine profile and growth factors in platelet-rich plasma obtained by open systems and commercial columns. Einstein (Sao Paulo) 14:391–397. https://doi.org/10.1590/S1679-45082016AO3548
doi: 10.1590/S1679-45082016AO3548 pubmed: 27759829
Kim HO, Kim H-S, Youn J-C et al (2011) Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays. J Transl Med 9:113. https://doi.org/10.1186/1479-5876-9-113
doi: 10.1186/1479-5876-9-113 pubmed: 21774806 pmcid: 3146842
Pockley AG, Foulds GA, Oughton JA et al (2015) Immune cell phenotyping using flow cytometry. Curr Protoc Toxicol 66:18.8.1–18.8.34
Givan AL (2004) Flow cytometry: an introduction. Methods Mol Biol 263:1–32. https://doi.org/10.1385/1-59259-773-4:001
doi: 10.1385/1-59259-773-4:001 pubmed: 14976358
Lucas F, Gil-Pulido J, LaMacchia J et al (2020) MiSet RFC standards: defining a universal minimum set of standards required for reproducibility and rigor in research flow cytometry experiments. Cytometry A 97:148–155. https://doi.org/10.1002/cyto.a.23940
doi: 10.1002/cyto.a.23940 pubmed: 31769204
Mohr H, Lambrecht B, Bayer A et al (2006) Basics of flow cytometry-based sterility testing of platelet concentrates. Transfusion 46:41–49. https://doi.org/10.1111/j.1537-2995.2005.00668.x
doi: 10.1111/j.1537-2995.2005.00668.x pubmed: 16398729
Miron RJ, Fujioka-Kobayashi M, Sculean A, Zhang Y (2024) Optimization of platelet-rich fibrin. Periodontol 2000 94:79–91. https://doi.org/10.1111/prd.12521

Auteurs

António Melo-Ferraz (A)

UNIPRO - Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), CESPU, CRL, Gandra, 4585-116, Portugal.

Cristina Coelho (C)

UNIPRO - Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), CESPU, CRL, Gandra, 4585-116, Portugal.

Paulo Miller (P)

UNIPRO - Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), CESPU, CRL, Gandra, 4585-116, Portugal. paulo.miller@iucs.cespu.pt.

Maria Begoña Criado (MB)

1H-TOXRUN - One Health Toxicology Research Unit, University Institute of Health Sciences (IUCS), CESPU, CRL, Gandra, 4585-116, Portugal.

Maria Céu Monteiro (MC)

1H-TOXRUN - One Health Toxicology Research Unit, University Institute of Health Sciences (IUCS), CESPU, CRL, Gandra, 4585-116, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH